Abbott has received Food and Drug Administration (FDA) clearance for a reader for its newest continuous glucose monitoring (CGM) system in the USA. Its FreeStyle
An investigational outpatient endoscopic procedure may help eliminate the need for insulin in people with Type 2 diabetes, early research suggests. Called re-cellularization via electroporation
Embecta, the largest maker of disposable pen needles and insulin syringes for people withy diabetes, has announced plans to develop its own insulin pump, signaling
Innovation Zed, a company based in Ireland, specialises in the development of innovative medical devices. It has partnered with GluCare.Health, a leading metabolic disease management
Medtronic has begun working with computer chip maker Nvidia on a platform for artificial intelligence applications to run on its medical devices. The companies hope
Sernova Corp has announced that the first two patients in the second cohort of its active U.S. Phase 1/2 clinical trial for the treatment of
Glooko, Inc has announced a new global partnership with Hedia, integrating its technology into Glooko’s diabetes management platforms for healthcare providers and people with diabetes.
In the latest move towards finding a stem cell-based cure for Type 1 diabetes, American company Vertex has announced a new agreement with CRISPR Therapeutics
A recent article in Scientific American is reporting that telehealth is now being used in new medical areas, such as in cancer care in the
Scientists at the University of Sussex have successfully trialed new biodegradable health sensors – such as those worn by runners or patients to monitor heart
